| Robert Matthew Shulman, MD | |
|
14 Research Pl, 3rd Floor, N Chelmsford, MA 01863-2412 | |
| (978) 256-6607 | |
| (978) 250-8189 |
| Full Name | Robert Matthew Shulman |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 49 Years |
| Location | 14 Research Pl, N Chelmsford, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588611545 | NPI | - | NPPES |
| 2085429 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 41318 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tufts Medical Center | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cardiovascular Center At Tufts Medical Center Inc | 3870857816 | 96 |
News Archive
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas.
Consumers who queue up for health screenings at the mall, a senior center, a drug store or other retail business could benefit from the information they learn.
A recent study demonstrates that antibodies generated in response to mRNA-based COVID-19 vaccination target more epitopes across the spike protein.
Researchers find changes to protein SirT1 can prevent excess metabolic stress associated with obesity, diabetes and aging.
› Verified 8 days ago
| Entity Name | Pratt Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275570319 PECOS PAC ID: 3375515661 Enrollment ID: O20040807000255 |
News Archive
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas.
Consumers who queue up for health screenings at the mall, a senior center, a drug store or other retail business could benefit from the information they learn.
A recent study demonstrates that antibodies generated in response to mRNA-based COVID-19 vaccination target more epitopes across the spike protein.
Researchers find changes to protein SirT1 can prevent excess metabolic stress associated with obesity, diabetes and aging.
› Verified 8 days ago
| Entity Name | Cardiovascular Center At Tufts Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447764253 PECOS PAC ID: 3870857816 Enrollment ID: O20180430000179 |
News Archive
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas.
Consumers who queue up for health screenings at the mall, a senior center, a drug store or other retail business could benefit from the information they learn.
A recent study demonstrates that antibodies generated in response to mRNA-based COVID-19 vaccination target more epitopes across the spike protein.
Researchers find changes to protein SirT1 can prevent excess metabolic stress associated with obesity, diabetes and aging.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Matthew Shulman, MD 14 Research Pl, 3rd Floor, N Chelmsford, MA 01863-2412 Ph: (978) 256-6607 | Robert Matthew Shulman, MD 14 Research Pl, 3rd Floor, N Chelmsford, MA 01863-2412 Ph: (978) 256-6607 |
News Archive
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas.
Consumers who queue up for health screenings at the mall, a senior center, a drug store or other retail business could benefit from the information they learn.
A recent study demonstrates that antibodies generated in response to mRNA-based COVID-19 vaccination target more epitopes across the spike protein.
Researchers find changes to protein SirT1 can prevent excess metabolic stress associated with obesity, diabetes and aging.
› Verified 8 days ago
Brian Cullingford, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 14 Research Pl, N Chelmsford, MA 01863 Phone: 978-256-6607 | |
Michael G Bertos, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 20 Research Pl, Suite 310, N Chelmsford, MA 01863 Phone: 978-459-2152 | |
Walter Moon Jo, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 14 Research Pl, N Chelmsford, MA 01863 Phone: 978-256-6607 Fax: 978-250-8189 | |
Kirk John Macnaught, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 14 Research Pl, N Chelmsford, MA 01863 Phone: 978-256-6607 Fax: 978-250-8189 | |
Louis J Bresnick, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 20 Research Pl, Suite 310, N Chelmsford, MA 01863 Phone: 978-459-2152 | |
Richard Gartner Birkhead, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 14 Research Pl, N Chelmsford, MA 01863 Phone: 978-256-6607 Fax: 978-250-8189 | |
Miret Ibrahim, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 14 Research Pl, N Chelmsford, MA 01863 Phone: 978-256-6607 |